Skip to main content

Table 2 Tracing of the effects of combined therapy on AFP, number and size of focal lesions during the follow up period

From: Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience

  1 month 4th month 7th month 10th month Basal
AFP 57 ± 17.5 6.9 ± 1.5 7.1 ± 1.1 21.3 ± 9.4 6211.3 ± 929
p (0.000) (0.000) (0.6) (0.4)
No of lesions 2.4 ± 1 1.47 ± 0.6 0.93 ± 0.4 0.73 ± 0.34 2.5 ± 1.1
P (p = 0.8) (p = 0.000) (p = 0.001) (p = 0.2)
Size of lesions 6.4 ± 2.9 3.8 ± 1.8 2.2 ± 1.4 2.2 ± 0.9 10.4 ± 4.1
p (p = 0.000) (p = 0.000) (p = 0.001) (p = 0.8)